Post-Authorisation Safety Study (PASS) for Flupirtine – Effect of Risk Minimisation Measures in Germany

01/08/2016
31/03/2024
EU PAS number:
EUPAS14528
Study
Finalised
Documents
Study protocol
Initial protocol
English (473.17 KB - PDF) View document
Study results
Study results
English (47.75 KB - PDF) View document
Study report
Other information